201 related articles for article (PubMed ID: 28744752)
1. Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers.
Withrow DR; Morton LM; Curtis RE; Schonfeld SJ; Berrington de González A
Breast Cancer Res Treat; 2017 Nov; 166(1):299-306. PubMed ID: 28744752
[TBL] [Abstract][Full Text] [Related]
2. Association of lifestyle and clinical characteristics with receipt of radiotherapy treatment among women diagnosed with DCIS in the NIH-AARP Diet and Health Study.
Mullooly M; Withrow DR; Curtis RE; Fan S; Liao LM; Pfeiffer RM; de González AB; Gierach GL
Breast Cancer Res Treat; 2020 Jan; 179(2):445-457. PubMed ID: 31625031
[TBL] [Abstract][Full Text] [Related]
3. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
[TBL] [Abstract][Full Text] [Related]
4. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
Gao X; Fisher SG; Emami B
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
[TBL] [Abstract][Full Text] [Related]
5. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.
Berrington de Gonzalez A; Curtis RE; Gilbert E; Berg CD; Smith SA; Stovall M; Ron E
Br J Cancer; 2010 Jan; 102(1):220-6. PubMed ID: 19935795
[TBL] [Abstract][Full Text] [Related]
6. Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer.
Kushner CJ; Hwang WT; Wang S; Solin LJ; Vapiwala N
Breast Cancer Res Treat; 2018 Jul; 170(1):45-53. PubMed ID: 29488126
[TBL] [Abstract][Full Text] [Related]
7. Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.
Corradini S; Pazos M; Schönecker S; Reitz D; Niyazi M; Ganswindt U; Schrodi S; Braun M; Pölcher M; Mahner S; Harbeck N; Engel J; Belka C
Radiat Oncol; 2018 Feb; 13(1):25. PubMed ID: 29426355
[TBL] [Abstract][Full Text] [Related]
8. Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
Curigliano G; Disalvatore D; Esposito A; Pruneri G; Lazzeroni M; Guerrieri-Gonzaga A; Luini A; Orecchia R; Goldhirsch A; Rotmensz N; Bonanni B; Viale G
Ann Oncol; 2015 Apr; 26(4):682-687. PubMed ID: 25600567
[TBL] [Abstract][Full Text] [Related]
9. Do we need to irradiate all small invasive breast cancers and DCIS?
White J
Am Soc Clin Oncol Educ Book; 2013; ():40-4. PubMed ID: 23714451
[TBL] [Abstract][Full Text] [Related]
10. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
[TBL] [Abstract][Full Text] [Related]
11. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
[TBL] [Abstract][Full Text] [Related]
12. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series.
Leonardi MC; Corrao G; Frassoni S; Vingiani A; Dicuonzo S; Lazzeroni M; Fodor C; Morra A; Gerardi MA; Rojas DP; Dell'Acqua V; Marvaso G; Bassi FD; Galimberti VE; Veronesi P; Miglietta E; Cattani F; Zurrida S; Bagnardi V; Viale G; Orecchia R; Jereczek-Fossa BA
Radiother Oncol; 2019 Apr; 133():68-76. PubMed ID: 30935584
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in risk of second breast tumors after ductal carcinoma in situ.
Liu Y; Colditz GA; Gehlert S; Goodman M
Breast Cancer Res Treat; 2014 Nov; 148(1):163-73. PubMed ID: 25261293
[TBL] [Abstract][Full Text] [Related]
15. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.
Berrington de Gonzalez A; Curtis RE; Kry SF; Gilbert E; Lamart S; Berg CD; Stovall M; Ron E
Lancet Oncol; 2011 Apr; 12(4):353-60. PubMed ID: 21454129
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.
van Maaren MC; Lagendijk M; Tilanus-Linthorst MMA; de Munck L; Pijnappel RM; Schmidt MK; Wesseling J; Koppert LB; Siesling S
Eur J Cancer; 2018 Sep; 101():134-142. PubMed ID: 30059817
[TBL] [Abstract][Full Text] [Related]
17. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
Innos K; Horn-Ross PL
Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
Smith BD; Haffty BG; Buchholz TA; Smith GL; Galusha DH; Bekelman JE; Gross CP
J Natl Cancer Inst; 2006 Sep; 98(18):1302-10. PubMed ID: 16985249
[TBL] [Abstract][Full Text] [Related]
19. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
[TBL] [Abstract][Full Text] [Related]
20. Modern Trends in the Surgical Management of Paget's Disease.
Wong SM; Freedman RA; Stamell E; Sagara Y; Brock JE; Desantis SD; Golshan M
Ann Surg Oncol; 2015 Oct; 22(10):3308-16. PubMed ID: 26202552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
